Tenon Medical Files Q2 2024 10-Q Report

TL;DR

Tenon Medical filed its 10-Q for Q2 2024. Check financials.

AI Summary

Tenon Medical, Inc. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, incorporated in Delaware, is involved in the surgical and medical instruments and apparatus industry. Its principal executive offices are located at 104 Cooper Court, Los Gatos, CA.

Why It Matters

This filing provides investors with an update on Tenon Medical's financial performance and operational status for the second quarter of 2024.

Risk Assessment

Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.

Key Numbers

• 001-41364 — SEC File Number (Identifies the company's filings with the SEC.)
• 45-5574718 — IRS Number (Company's Employer Identification Number.)

Key Players & Entities

• Tenon Medical, Inc. (company) — Registrant
• June 30, 2024 (date) — Quarterly period end date
• 104 Cooper Court, Los Gatos, CA 95032 (location) — Principal executive offices
• 3841 (number) — Standard Industrial Classification Code

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Market

Filing Documents

• ea0210949-10q_tenon.htm (10-Q) — 593KB
• ea021094901ex31-1_tenon.htm (EX-31.1) — 9KB
• ea021094901ex31-2_tenon.htm (EX-31.2) — 9KB
• ea021094901ex32-1_tenon.htm (EX-32.1) — 4KB
• ea021094901ex32-2_tenon.htm (EX-32.2) — 4KB
• 0001213900-24-068416.txt ( ) — 4051KB
• tnon-20240630.xsd (EX-101.SCH) — 39KB
• tnon-20240630_cal.xml (EX-101.CAL) — 34KB
• tnon-20240630_def.xml (EX-101.DEF) — 209KB
• tnon-20240630_lab.xml (EX-101.LAB) — 395KB
• tnon-20240630_pre.xml (EX-101.PRE) — 206KB
• ea0210949-10q_tenon_htm.xml (XML) — 347KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1. Condensed Consolidated Financial Statements (unaudited) 1 Condensed Consolidated Balance Sheets 1 Condensed Consolidated Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity 3 Condensed Consolidated Statements of Cash Flows 5 Notes to Condensed Consolidated Financial Statements 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 22 Item 4.

Controls and Procedures

Controls and Procedures 22

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 23 Item 1A.

Risk Factors

Risk Factors 23 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 23 Item 3. Defaults Upon Senior Securities 23 Item 4. Mine Safety Disclosures 23 Item 5. Other Information 23 Item 6. Exhibits 24

SIGNATURES

SIGNATURES 25 i CAUTIONARY This Quarterly Report on Form 10-Q contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends impacting the financial condition of our business. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management's good faith belief as of that time with respect to future events and are by the forward-looking statements. Forward-looking such as "may," "will," "should," "could," "would," "expect," "intend," "seek," "plan," "anticipate," "believe," "estimate," "project," "predict," "potential," "might," "forecast," "continue," or the negative of those terms, and similar expressions and comparable terminology intended to reference future periods. Forward-looking Our ability to effectively operate our business; Our ability to manage our research, development, expansion, growth and operating expenses; Our ability to evaluate and measure our business, prospects and performance metrics; Our ability and our distributors' ability to compete

View Full Filing

View this 10-Q filing on SEC EDGAR